Sellas Life Current Valuation vs. EBITDA

SLS Stock  USD 1.17  0.03  2.50%   
Based on the measurements of profitability obtained from Sellas Life's financial statements, Sellas Life Sciences may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in December. Profitability indicators assess Sellas Life's ability to earn profits and add value for shareholders. At this time, Sellas Life's Price To Sales Ratio is comparatively stable compared to the past year. EV To Sales is likely to gain to 47.23 in 2024, despite the fact that Operating Cash Flow Sales Ratio is likely to grow to (26.01). At this time, Sellas Life's Non Operating Income Net Other is comparatively stable compared to the past year. Interest Income is likely to gain to about 674.1 K in 2024, whereas Income Before Tax is likely to drop (39.2 M) in 2024.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.70.81
Fairly Down
Pretty Stable
For Sellas Life profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Sellas Life to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Sellas Life Sciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Sellas Life's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Sellas Life Sciences over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sellas Life. If investors know Sellas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sellas Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.67)
Quarterly Revenue Growth
(0.82)
Return On Assets
(1.29)
Return On Equity
(8.88)
The market value of Sellas Life Sciences is measured differently than its book value, which is the value of Sellas that is recorded on the company's balance sheet. Investors also form their own opinion of Sellas Life's value that differs from its market value or its book value, called intrinsic value, which is Sellas Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sellas Life's market value can be influenced by many factors that don't directly affect Sellas Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sellas Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sellas Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sellas Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Sellas Life Sciences EBITDA vs. Current Valuation Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Sellas Life's current stock value. Our valuation model uses many indicators to compare Sellas Life value to that of its competitors to determine the firm's financial worth.
Sellas Life Sciences is rated below average in current valuation category among its peers. It is rated second in ebitda category among its peers totaling about  0.01  of EBITDA per Current Valuation. The ratio of Current Valuation to EBITDA for Sellas Life Sciences is roughly  117.00 . At this time, Sellas Life's EBITDA is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Sellas Life by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Sellas Current Valuation vs. Competition

Sellas Life Sciences is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 7.34 Billion. Sellas Life maintains roughly 61.89 Million in current valuation contributing less than 1% to equities under Health Care industry.

Sellas EBITDA vs. Current Valuation

Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Sellas Life

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
61.89 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Sellas Life

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
529 K
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Sellas EBITDA Comparison

Sellas Life is currently under evaluation in ebitda category among its peers.

Sellas Life Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Sellas Life, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Sellas Life will eventually generate negative long term returns. The profitability progress is the general direction of Sellas Life's change in net profit over the period of time. It can combine multiple indicators of Sellas Life, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income-37.9 M-39.8 M
Income Before Tax-37.3 M-39.2 M
Net Loss-37.3 M-39.2 M
Total Other Income Expense Net529 K502.6 K
Income Tax Expense-37.9 M-36 M
Net Loss-38.3 M-40.2 M
Non Operating Income Net Other239.2 K251.2 K
Net Loss-47.5 M-49.9 M
Interest Income642 K674.1 K
Net Interest Income642 K674.1 K
Change To Netincome13.6 M14.3 M
Net Loss(1.34)(1.41)
Income Quality 0.84  0.80 
Net Income Per E B T 1.13  1.28 

Sellas Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Sellas Life. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Sellas Life position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Sellas Life's important profitability drivers and their relationship over time.

Use Sellas Life in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sellas Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sellas Life will appreciate offsetting losses from the drop in the long position's value.

Sellas Life Pair Trading

Sellas Life Sciences Pair Trading Analysis

The ability to find closely correlated positions to Sellas Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sellas Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sellas Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sellas Life Sciences to buy it.
The correlation of Sellas Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sellas Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sellas Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sellas Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Sellas Life position

In addition to having Sellas Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Monster Funds Thematic Idea Now

Monster Funds
Monster Funds Theme
Solid funds with above average long term performance indicators based on Macroaxis rating system. The Monster Funds theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Monster Funds Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Sellas Stock Analysis

When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.